Fri, Dec 26, 2014, 8:43 AM EST - U.S. Markets open in 47 mins.


% | $
Quotes you view appear here for quick access.


  • barbing1965 barbing1965 Jun 26, 2010 8:28 PM Flag

    Scenario #2

    RNAi is fast becoming the next great science to fight all types of disease at the cell level. RNAi companies are having a hard time figuring out how to deliver their next gen drugs effectively to the cells. ACCP could look very attractive to an RNAi company because of their Cobalamin technology. This company has great technology. Any way you look at it, this company will make it on their own or be bought out by another company that would like to get their hands on their technology. At 2+ a share and a market cap of a little over 30 mil, don't be surprised if you wake up one morning and see AACP bought out at a much higher price.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.220.00(0.00%)Oct 23 3:58 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Gilead Sciences Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Spectrum Pharmaceuticals, Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST